Additionally, our data showed that the induction of diabetes in rats via STZ administration clearly caused higher ALT and ALP levels, and treatment with 250 mg kg−1 (b.i.d.)SynacinnTM normalized the levels by 60% and 90%. This evidence concerns the gene GPT and diabetes mellitus.